Dermatological carbon dioxide laser system - ARTG 273658
Access comprehensive regulatory information for Dermatological carbon dioxide laser system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 273658 and sponsored by Ebos Medical Devices Australia Pty Ltd, manufactured by Ilooda Co Ltd in South Korea. The device registration started on March 31, 2016.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
FRAXIS is a surgical dermatological carbon dioxide laser system used to conduct microfractional laser resurfacing, promoting the reconstruction of both epidermis and dermis. Its uses include the treatment of acne scars, aging skin lesions and various skin renewal and rejuvenation applications. The laser system and its accessories are not intended for gynaecological procedures including but not limited to the treatment of diminished sensation during intercourse; dryness, loss of lubrication and pain during intercourse; vaginal pain or discomfort; vaginal laxity (looseness) and trophy, urinary incontinence and urgency, vaginal itchiness and discomfort, vulva tightening and lightening, and recurrent thrush.